Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of HRS4800 in Healthy Male Subjects
NCT04862884Phase 1Unknown
- Sponsor
- Hengrui
- Start
- May 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in pain comparing HRS4800 with Placebo (2 arms). Primary endpoints: Proportion of Participants with Adverse Events, Proportion of Participants with Hematology, Clinical Chemistry, Urinalysis Laboratory Abnormalities and 2 more. Status: unknown.
02
Drugs
HRS-4800
03
Conditions
pain
Beyond the preview
Go deeper on NCT04862884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04862884.